At UK£0.20, Is hVIVO plc (LON:HVO) Worth Looking At Closely?
Nov 30
U.K. (FTSE) Life Sciences Industry Analysis
UpdatedDec 01, 2023
DataAggregated Company Financials
Companies12
- 7D3.8%
- 3M-4.7%
- 1Y-17.7%
- YTD-15.4%
Over the last 7 days, the Life Sciences industry has risen 3.8%, driven by gains from Oxford Nanopore Technologies of 4.2%. During this same period, the Oxford BioDynamics underperformed, falling 13%. However, the industry is down 18% over the past year. Looking forward, earnings are forecast to grow by 19% annually.
Industry Valuation and Performance
Has the U.K. Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 01 Dec 2023 | UK£3.1b | UK£455.3m | -UK£168,440,958.00 | 51.1x | -18.3x | 6.8x |
| Sun, 29 Oct 2023 | UK£3.0b | UK£458.8m | -UK£165,732,145.00 | 46.7x | -18x | 6.5x |
| Tue, 26 Sep 2023 | UK£3.0b | UK£447.9m | -UK£167,477,541.00 | 67.5x | -18.2x | 6.8x |
| Thu, 24 Aug 2023 | UK£3.1b | UK£476.1m | -UK£126,529,840.00 | 70.6x | -24.6x | 6.5x |
| Sat, 22 Jul 2023 | UK£3.5b | UK£476.2m | -UK£124,500,480.00 | 69.6x | -27.8x | 7.3x |
| Mon, 19 Jun 2023 | UK£3.0b | UK£476.3m | -UK£124,557,908.00 | 64.4x | -24.4x | 6.4x |
| Wed, 17 May 2023 | UK£3.1b | UK£477.7m | -UK£122,733,107.00 | 36.7x | -25.6x | 6.6x |
| Fri, 14 Apr 2023 | UK£3.0b | UK£458.5m | -UK£118,742,286.00 | 33.5x | -25.6x | 6.6x |
| Sun, 12 Mar 2023 | UK£2.9b | UK£443.7m | -UK£183,261,487.00 | 42.3x | -16x | 6.6x |
| Tue, 07 Feb 2023 | UK£3.5b | UK£443.8m | -UK£183,177,378.00 | 47.2x | -19.2x | 7.9x |
| Thu, 05 Jan 2023 | UK£3.5b | UK£443.6m | -UK£183,014,525.00 | 48.4x | -18.9x | 7.8x |
| Sat, 03 Dec 2022 | UK£3.7b | UK£446.3m | -UK£178,824,932.00 | 51.8x | -20.9x | 8.4x |
| Mon, 31 Oct 2022 | UK£3.7b | UK£448.1m | -UK£175,999,972.00 | 46.1x | -21.1x | 8.3x |
| Wed, 28 Sep 2022 | UK£3.3b | UK£450.7m | -UK£177,346,348.00 | 42.6x | -18.6x | 7.3x |
| Fri, 26 Aug 2022 | UK£3.7b | UK£369.6m | -UK£189,812,025.00 | 46.4x | -19.6x | 10.1x |
| Sun, 24 Jul 2022 | UK£3.7b | UK£366.8m | -UK£188,140,292.00 | 39x | -19.9x | 10.2x |
| Tue, 21 Jun 2022 | UK£3.8b | UK£363.9m | -UK£189,505,399.00 | 37.5x | -19.9x | 10.4x |
| Thu, 19 May 2022 | UK£3.5b | UK£361.6m | -UK£191,670,938.00 | 39.5x | -18.5x | 9.8x |
| Sat, 16 Apr 2022 | UK£6.2b | UK£929.9m | -UK£312,315,184.00 | 48.5x | -19.9x | 6.7x |
| Mon, 14 Mar 2022 | UK£6.4b | UK£892.0m | -UK£203,338,588.00 | 43.6x | -31.6x | 7.2x |
| Wed, 09 Feb 2022 | UK£7.6b | UK£848.8m | -UK£185,924,166.00 | 30.9x | -41.1x | 9x |
| Fri, 07 Jan 2022 | UK£8.9b | UK£849.1m | -UK£184,776,347.00 | 30.8x | -48.1x | 10.5x |
| Sun, 05 Dec 2021 | UK£9.2b | UK£844.3m | -UK£192,212,129.00 | 26.3x | -47.9x | 10.9x |
| Tue, 02 Nov 2021 | UK£8.4b | UK£840.9m | -UK£201,961,582.00 | 26.7x | -41.6x | 10x |
| Thu, 30 Sep 2021 | UK£3.0b | UK£706.2m | -UK£130,350,268.00 | 29.2x | -23x | 4.2x |
| Sat, 28 Aug 2021 | UK£3.1b | UK£670.4m | -UK£160,499,800.35 | 69.6x | -19.4x | 4.7x |
| Sun, 04 Jul 2021 | UK£3.0b | UK£670.4m | -UK£160,499,800.35 | 61.5x | -18.6x | 4.5x |
| Wed, 07 Apr 2021 | UK£3.4b | UK£670.8m | -UK£88,500,847.08 | 70.2x | -38.8x | 5.1x |
| Sat, 09 Jan 2021 | UK£3.2b | UK£671.0m | -UK£14,838,270.60 | 69.6x | -212.8x | 4.7x |
Price to Earnings Ratio
16.2x
Current Industry PE
- Investors are pessimistic on the British Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 8.4x is higher than the industry's current PS ratio of 6.8x.
Past Earnings Growth
- Total earnings for the Life Sciences industry have declined over the last three years, with the industry now making a loss overall.
- Revenues have also declined 11% per year, which is driving profits down.
Industry Trends
Which industries have driven the changes within the U.K. Healthcare industry?
| GB Market | -0.55% | |
| Healthcare | -0.42% | |
| Life Sciences | 3.84% | |
| Clinical Research and Equipment | 3.84% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ONT Oxford Nanopore Technologies | UK£1.94 | 4.2% +UK£67.0m | -25.8% | PS10.2x | |
| MXCT MaxCyte | UK£3.78 | 8.6% +UK£31.1m | -23.3% | PS13x | |
| HVO hVIVO | UK£0.21 | 15.2% +UK£18.7m | 74.8% | PE49.2x | |
| ERGO Ergomed | UK£13.46 | 0.1% +UK£14.7m | 3.5% | PE46.7x | |
| DXRX Diaceutics | UK£0.93 | 3.4% +UK£2.5m | 22.5% | PE12992.2x |